Human medicines European public assessment report (EPAR): Lemtrada, alemtuzumab, Multiple Sclerosis, Date of authorisation: 12/09/2013, Revision: 22, Status: Authorised

Human medicines European public assessment report (EPAR): Lemtrada, alemtuzumab, Multiple Sclerosis, Date of authorisation: 12/09/2013, Revision: 22, Status: Authorised

Newsletters

Stay informed on our latest news!

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.

randomness